• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDIVATORS, INC. RAPICIDE PA HIGH LEVEL DISINFECTANT AND STERILANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDIVATORS, INC. RAPICIDE PA HIGH LEVEL DISINFECTANT AND STERILANT Back to Search Results
Model Number ML02-0117
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Unspecified Respiratory Problem (4464)
Event Date 10/27/2021
Event Type  malfunction  
Event Description
The user facility reported that an employee was exchanging rapicide pa high-level disinfectant/sterilant bottles in the advantage plus automated endoscope reprocessor (aer) and reported inhalation exposure to the disinfectant fumes.The employee sought medical assessment.The user facility did not disclose if medical treatment was determined to be required or administered.It was confirmed that the employee was able to return to work.
 
Manufacturer Narrative
Details of the products subject of the event were not provided to medivators.Further information regarding the event date, patient symptoms and duration of symptoms were not disclosed.Additionally, the use of ppe and the presence of sufficient environmental ventilation were not able to be confirmed.Medivators reached out to the user facility for further information on the event and to request product return for evaluation.To date, the user facility has not provided a response.The potential for user exposure to occur during disinfectant bottle exchange in the aer is a known hazard.Therefore, the following language can be found in the advantage plus aer operator manual (50097-429, rev j) on page 21 and 63 regarding ppe requirements when exchanging disinfectant bottles: "warning: avoid possible chemical burns.When replacing disinfectant, wear personal protective equipment (clothing, mask, gloves and eyewear." additionally, the rapicide pa high-level disinfectant/sterilant sds (50095-116, rev a) includes the following language regarding ppe and exposure control measures to be taken by users of the disinfectant, "use only outdoors or in a well-ventilated area and wear protective gloves/protective clothing/eye protection/face protection." no additional reports of adverse event or harm were received.No malfunctions of the reported aer and/or disinfectant was able to be confirmed.A follow-up mdr will be submitted should additional information be made available.
 
Manufacturer Narrative
Details of the products subject of the event were not provided to medivators.Further information regarding the event date, patient symptoms and duration of symptoms were not disclosed.Additionally, the use of ppe and the presence of sufficient environmental ventilation were not able to be confirmed.Medivators reached out to the user facility for further information on the event and to request product return for evaluation.To date, the user facility has not provided a response.The potential for user exposure to occur during disinfectant bottle exchange in the aer is a known hazard.Therefore, the following language can be found in the advantage plus aer operator manual (50097-429, rev j) on page 21 and 63 regarding ppe requirements when exchanging disinfectant bottles: "warning: avoid possible chemical burns.When replacing disinfectant, wear personal protective equipment (clothing, mask, gloves and eyewear." additionally, the rapicide pa high-level disinfectant/sterilant sds (50095-116, rev a) includes the following language regarding ppe and exposure control measures to be taken by users of the disinfectant, "use only outdoors or in a well-ventilated area and wear protective gloves/protective clothing/eye protection/face protection." no additional reports of adverse event or harm were received.No malfunctions of the reported aer and/or disinfectant was able to be confirmed.A follow-up mdr will be submitted should additional information be made available.
 
Event Description
The user facility reported that an employee was exchanging rapicide pa high-level disinfectant/sterilant bottles in the advantage plus automated endoscope reprocessor (aer) and reported inhalation exposure to the disinfectant fumes.The employee sought medical assessment.The user facility did not disclose if medical treatment was determined to be required or administered.It was confirmed that the employee was able to return to work.
 
Manufacturer Narrative
The steris legal department was contacted regarding a legal complaint that had been filed involving rapicide pa high level disinfectant.We reviewed our records and confirmed the event is the same event which was reported in mdr 2150060-2021-00029, filed december 14, 2021.A follow-up mdr will be submitted should additional information become available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RAPICIDE PA HIGH LEVEL DISINFECTANT AND STERILANT
Type of Device
HIGH LEVEL DISINFECTANT
Manufacturer (Section D)
MEDIVATORS, INC.
14605 28th avenue n
minneapolis MN 55447
Manufacturer (Section G)
MEDIVATORS, INC.
14605 28th avenue n
minneapolis MN 55447
Manufacturer Contact
daniel davy
9800 59th avenue n
plymouth, MN 55442
MDR Report Key13002497
MDR Text Key285824209
Report Number2150060-2021-00029
Device Sequence Number1
Product Code FEB
UDI-Device Identifier00677964090172
UDI-Public00677964090172
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K082988
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type User Facility
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 12/14/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberML02-0117
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/16/2021
Initial Date FDA Received12/14/2021
Supplement Dates Manufacturer Received11/16/2021
Supplement Dates FDA Received03/28/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
-
-